NASDAQ · QQQX
Nuveen Nasdaq 100 Dynamic Overwrite Fund
$30.87-$0.12 (-0.39%)
Nuveen Nasdaq 100 Dynamic Overwrite Fund’s quoted price sits in the upper half of its reported 52-week range, 3.14% below the high.
Loading market information…
NYSE · NMZ · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Nuveen Municipal High Income Opportunity Fund’s quoted price sits in the lower half of its reported 52-week range, 16.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Nuveen Municipal High Income Opportunity Fund’s forward annual dividend is $0.79 per share, paid monthly. The forward yield is 8.75% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nuveen Municipal High Income Opportunity Fund’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in the United States on November 19, 2003, the Nuveen Municipal High Income Opportunity Fund operates as a closed-end fixed income mutual fund. Nuveen Investments Inc. originally launched this fund, which is now jointly managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. Its investment strategy concentrates on the US fixed income markets, specifically targeting investment-grade, tax-exempt municipal securities as its primary holdings. This fund was previously identified as the Nuveen Municipal High Yield Opportunity Fund.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$30.87-$0.12 (-0.39%)
Nuveen Nasdaq 100 Dynamic Overwrite Fund’s quoted price sits in the upper half of its reported 52-week range, 3.14% below the high.
$13.26-$0.28 (-2.07%)
Nuveen S&P 500 Buy-Write Income Fund’s quoted price sits in the upper half of its reported 52-week range, 11.6% below the high.
$14.49$0.00 (0.0%)
Virtus Dividend, Interest & Premium Strategy Fund’s quoted price sits in the upper half of its reported 52-week range, 8.0% below the high.
$19.19+$0.10 (+0.52%)
Payden Equity Income Fund’s quoted price sits in the upper half of its reported 52-week range, 1.24% below the high.
$7.26+$0.08 (+1.11%)
Nuveen Floating Rate Income Fund’s quoted price sits in the lower half of its reported 52-week range, 9.25% below the high.
$9.89+$0.11 (+1.12%)
DoubleLine Income Solutions Fund’s quoted price sits in the lower half of its reported 52-week range, 16.4% below the high.
$13.28$0.00 (0.0%)
T. Rowe Price Retirement 2005 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.41% below the high.
$19.18-$0.10 (-0.52%)
Principal LifeTime 2055 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.64% below the high.
